Patient Guide: Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 71 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05058404
Status: ACTIVE_NOT_RECRUITING
Condition: Follicular Lymphoma
Phase: PHASE3

Where You Can Participate

This study is available at 71 locations across the country.

Top locations include:
  • • Barletta, Barletta Andria Trani
  • • San Giovanni Rotondo, Foggia
  • • Meldola, Forlì - Cesena
  • • And 68 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma - Join Clinical Trial NCTNCT05058404

How to Join This Clinical Trial - NCTNCT05058404

Learn how to participate in this PHASE3 trial studying an investigational therapy for Follicular Lymphoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Follicular Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Follicular Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05058404 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 71 locations. Find a study site near you:

Clinical Research Site

Barletta, Barletta Andria Trani 76121 - Italy

Status: Contact for availability

Clinical Research Site

San Giovanni Rotondo, Foggia 71013 - Italy

Status: Contact for availability

Clinical Research Site

Meldola, Forlì - Cesena 47014 - Italy

Status: Contact for availability

Clinical Research Site

Tricase, Lecce 73039 - Italy

Status: Contact for availability

Clinical Research Site

Sassuolo, Modena 41049 - Italy

Status: Contact for availability

Clinical Research Site

Monza, Monza E Brianza 20900 - Italy

Status: Contact for availability

Clinical Research Site

Aviano, Pordenone 33081 - Italy

Status: Contact for availability

Clinical Research Site

Pagani, Salerno 84016 - Italy

Status: Contact for availability

Clinical Research Site

Candiolo, Torino 10060 - Italy

Status: Contact for availability

Clinical Research Site

Castelfranco Veneto, Treviso 31033 - Italy

Status: Contact for availability

And 61 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Follicular Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships